Centro Oncologico de Galicia
About Centro Oncologico de Galicia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Spanish Breast Cancer Research Group
18
Hoffmann-La Roche
7
Centro Nacional de Investigaciones Oncologicas CARLOS III
3
Grupo Espanol Multidisciplinario del Cancer Digestivo
3
MedSIR
3
Pfizer
3
Clovis Oncology, Inc.
2
Fondazione Michelangelo
2
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
2
Grupo Gallego de Investigaciones Oncologicas
2
Puma Biotechnology, Inc.
2
Clinical Trials at Centro Oncologico de Galicia
During the past decade, Centro Oncologico de Galicia conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 24 clinical trials were completed, i.e. on
average, 70.6% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 6 clinical trials were completed. i.e. 60%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients
2003-09-19
2013-10-01
Completed
1,925
Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer
1999-11-01
2007-12-01
Completed
1,289
EC Followed Docetaxel Versus ET Followed Capecitabine as Adjuvant Chemotherapy for Node Positive Operable Breast Cancer
2004-02-01
2019-04-04
Completed
1,384
Maintenance Treatment With Capecitabine Versus Observation in Breast Cancer Patients
2006-01-01
2017-02-17
Completed
876
An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine
2004-12-01
2007-09-01
Terminated
62
Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer
2006-02-15
2009-07-14
Completed
49
Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole
2007-11-01
2016-07-01
Terminated
870
Bevacizumab + Endocrine Treatment vs Endocrine Treatment as First Line in Postmenopausal Women
2007-11-06
2014-07-24
Completed
380
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Centro Oncologico de Galicia" #1 sponsor was "Spanish Breast Cancer Research Group" with 18 trials, followed by "Hoffmann-La Roche" with 7 trials
sponsored, "Centro Nacional de Investigaciones Oncologicas CARLOS III" with 3 trials sponsored, "Grupo Espanol Multidisciplinario del Cancer Digestivo" with 3 trials sponsored and "MedSIR"
with 3 trials sponsored. Other sponsors include 30 different institutions and
companies that sponsored additional 32 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Oncologico de Galicia"
#1 collaborator was "Hoffmann-La Roche" with 8 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Pfizer" with 5 trials as a collaborator, "Breast International Group" with 4 trials as a collaborator and "Amgen" with 3 trials as a collaborator. Other collaborators include 38 different institutions and companies that were
collaborators in the rest 39 trials.
Clinical Trials Conditions at Centro Oncologico de Galicia
According to Clinical.Site data, the most researched conditions in "Centro Oncologico de Galicia" are
"Breast Cancer" (24 trials), "Breast Neoplasms" (4 trials), "Advanced Breast Cancer" (3 trials), "Advanced Prostate Cancer" (3 trials) and "Metastatic Breast Cancer" (3 trials). Many other conditions were trialed in "Centro Oncologico de Galicia" in a lesser frequency.
Clinical Trials Intervention Types at Centro Oncologico de Galicia
Most popular intervention types in "Centro Oncologico de Galicia" are "Drug" (58 trials), "Other" (3 trials), "Radiation" (3 trials), "Biological" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (10 trials), "Trastuzumab" (10 trials), "Paclitaxel" (9 trials), "Capecitabine" (6 trials) and "Docetaxel" (6 trials). Other intervention names were less common.
Clinical Trials Genders at Centro Oncologico de Galicia
The vast majority of trials in "Centro Oncologico de Galicia" are
33 trials for "All" genders, 31 trials for "Female" genders and 5 trials for "Male" genders.
Clinical Trials Status at Centro Oncologico de Galicia
Currently, there are NaN active trials in "Centro Oncologico de Galicia".
undefined are not yet recruiting,
7 are recruiting,
13 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 37 completed trials in Centro Oncologico de Galicia,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Centro Oncologico de Galicia, 3 "Phase 1"
clinical trials were conducted, 26 "Phase 2" clinical
trials and 24 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".